Former FDA commissioner Scott Gottlieb will keynote AAM's annual meeting
The Association for Accessible Medicines announced that Scott Gottlieb, former Food and Drug Administration commissioner and leading healthcare expert, will be the keynote speaker at the AAM's annual meeting, Access! 2025.
The meeting will be held Feb. 3-5 at The Ritz-Carlton in Amelia Island.
[Read more: Challenges continue, but generics companies see a bright future with biosimilars]
Gottlieb also will moderate the CEOs Unplugged session, where healthcare executives will share their candid insights and industry perspectives.
AAM’s annual meeting Access! 2025 brings together policymakers, influential speakers and industry leaders to chart the future of generics and biosimilars.
[Read more: AAM report: Generics, biosimilars generate $445B in savings ]